10-Year Treasury Yield Rises to 5.180% This Week -- Data Talk
Dow Jones2026/09/25 19:32The 10-year yield rose 0.185 percentage point to 5.180% this week. The price fell 1 13/32 to 95 24/32.
--Yield is up for four consecutive weeks
--Yield is up 0.459 percentage point over the last four weeks
--Largest four-week yield gain since the week ending March 27, 2026
--Longest streak of rising yields since the week ending March 27, 2026 when the yield rose for four straight weeks
--Yield is up 10 of the past 13 weeks
--Today it is up 0.017 percentage point and the price fell 4/32 price points
--Yield is up for four consecutive trading days
--Yield is up 0.218 percentage point over the last four trading days
--Largest four-day yield gain since Tuesday, May 13, 2025
--Longest streak of rising yields since Friday, Sept. 11, 2026, when the yield rose for five straight trading days
--Yield is up 12 of the past 15 trading days
--A new 52-week high
--Highest yield since Friday, July 6, 2007,
--Yield is up 1.228 percentage points from its 52-week low of 3.952% hit Wednesday, Oct. 22, 2025
--Yield is up 0.995 percentage point from 52 weeks ago
--Yield is up 1.219 percentage points from its 2026 closing low of 3.961% hit Friday, Feb. 27, 2026
--Month-to-date the yield is up 0.423 percentage point
--Year-to-date the yield is up 1.028 percentage points
Data based on 3 p.m. ET values
Source: Tradeweb FTSE U.S. Treasury Closing Prices
(END) Dow Jones Newswires
September 25, 2026 15:32 ET (19:32 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Millennium International Management discloses net short position in Covivio shares

Sculptor Capital Management Europe discloses net short position in Exail Technologies
Vana Completes Expanded Staking as Part of the Vega Upgrade, Publishes Expanded VANA Token Economics
D.E. Shaw discloses net short position in Abivax shares